View in EDS

Intra-Treatment PET/MRI Separates Intermediate Risk p16-Positive Oropharynx Cancer Patients into Favorable and Unfavorable Cohorts.

Saved in:

Bibliographic Details
Title:	Intra-Treatment PET/MRI Separates Intermediate Risk p16-Positive Oropharynx Cancer Patients into Favorable and Unfavorable Cohorts.
Authors:	Witek, Matthew¹ (AUTHOR), Harari, Paul² (AUTHOR), Burr, Adam³ (AUTHOR), Chandereng, Thevaa⁴ (AUTHOR), Bruce, Justine¹ (AUTHOR), Kimple, Randall² (AUTHOR), Avey, Gregory⁴ (AUTHOR)
Source:	International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 2, pE40-E41. 2p.
Subjects:	Cancer patients, Oropharynx
Database:	Engineering Source

Description
ISSN:	03603016
DOI:	10.1016/j.ijrobp.2020.02.562